Neuronetics, Inc. (STIM) stock
STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.25+0.01 (+0.81%)
Close on Nov 20, 2026Market cap $95.25MP/E –Yield –
Neuronetics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Neuronetics's free cash flow for the twelve months ending Jun 30, 2026 was -$11.28M. For fiscal 2025 it was -$21.20M. The highest annual figure on record is -$8.87M in fiscal 2016.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$21.20M | – |
| FY2024 | Dec 31, 2024 | -$32.46M | – |
| FY2023 | Dec 31, 2023 | -$34.41M | – |
| FY2022 | Dec 31, 2022 | -$34.01M | – |
| FY2021 | Dec 31, 2021 | -$30.34M | – |
| FY2020 | Dec 31, 2020 | -$29.12M | – |
| FY2019 | Dec 31, 2019 | -$31.30M | – |
| FY2018 | Dec 31, 2018 | -$21.60M | – |
| FY2017 | Dec 31, 2017 | -$11.74M | – |
| FY2016 | Dec 31, 2016 | -$8.87M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.43M | – |
| Q1 FY2026 | Mar 31, 2026 | -$9.62M | – |
| Q4 FY2025 | Dec 31, 2025 | $666.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$899.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.76M | – |
| Q1 FY2025 | Mar 31, 2025 | -$17.21M | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.69M | -792.6% |
| Q3 FY2024 | Sep 30, 2024 | -$5.80M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.59M | – |
| Q1 FY2024 | Mar 31, 2024 | -$12.39M | – |
| Q4 FY2023 | Dec 31, 2023 | $1.25M | – |
| Q3 FY2023 | Sep 30, 2023 | -$10.68M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.54M | – |
| Q1 FY2023 | Mar 31, 2023 | -$15.45M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.60M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.23M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.92M | – |
| Q1 FY2022 | Mar 31, 2022 | -$13.26M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.33M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.96M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.21M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.84M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.82M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.69M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.70M | – |
| Q1 FY2020 | Mar 31, 2020 | -$13.92M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.76M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.72M | – |
| Q2 FY2019 | Jun 30, 2019 | -$6.97M | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.84M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.64M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.06M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.32M | – |
| Q1 FY2018 | Mar 31, 2018 | -$8.59M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.10M | – |
See a number that looks wrong?